Research

The study was the largest of its kind to date, examining the impact of medical cannabis on anxiety and depression in 7,362 Canadian patients

Canadian company set to focus clinical trials down under, announces regulatory update

As rates of mental health disorders increase the demand for psychedelic treatments do too

According to a recent report, 47 per cent of cannabis marketers reported having annual budgets less than $50,000

Company growth within Colombia and Europe responsible for financial success this quarter

MyHempisphere program to be tailored to each customer

Industry is set to expand by approximately US$155 billion between 2020-2030

Many distributors are choosing not to test their products for microbes, pesticides and heavy metals

Price is the main reason consumers purchase illegal cannabis, according to a recent report in the Journal of Studies on Alcohol and Drugs

Hapbee technology users saw improvements in quality of sleep, length of sleep, reduced restlessness, and reduced time to fall asleep

Up to 37 per cent experienced positive side effects such as feeling active, energetic, "frisky" or productive

The aim is to expand the evidence base on psilocybin-assisted psychotherapy to inform practical policies and regulations

Report outlines environmental, social and governance (ESG) priorities for the emerging global industry

Series of concerts across the U.S. and Canada will explore music’s role in psychedelic-assisted therapy

Nationwide cannabis sales declined for the second consecutive month to start 2022

A new report by New Frontier Data estimated that U.S. cannabis sales exceeded spirits (US$86 billion) last year, while matching spending on beer

The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds

But whether or not the disruption helps with the substance's antidepressant properties still needs further research

The study also found that seven out of ten patients did not suffer from adverse effects

The volatile compounds do more than just smell good

Previous experience was rated more important than shared symptoms, gender or ethnicity

But the data fails to account for the impact of the illicit market

Existing data is promising, but researchers urge more human trials be done

The firm owns rights to a treatment protocol used at a popular clinic in Cancun, Mexico

Cannabis prohibition today is outdated, unjust and inhumane, the Marijuana Policy Project says in a new report

Researchers note that treatment targeted at the start of symptoms was effective

The lobbying group includes tobacco giant Altria and beer maker Molson Coors

Statistics Canada also significantly revised its December data to reflect less sales in that month

The daily sales spike is steeper south of the border

Relative category performance is nearly double among Canadians compared to Americans

Wastewater analysis revealed higher per-capita levels of metabolites for cannabis, cocaine and MDMA

Mixing MDMA with heavier antidepressants can be fatal

Used in sacred traditions for centuries, the firm says research will bring their medicinal benefits to a larger audience

But most of the effects appeared to be subtle

The Mental Health Commission of Canada is calling for more inclusion of Black and other underrepresented groups in cannabis research

But there are some physiological differences between the two

By 2026, the firm expects most international sales growth to be led by Mexico and Germany

After starting treatment with pot, average opioid consumption dropped by 27%

Consumer spending on cannabis surpassed milk and energy drinks in 2021

The long-term benefits contrast with the more temporary effects of conventional antidepressants